Promising findings lead to initiation of a clinical efficacy trial in southern Africa

BOSTON - More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year. 

...

The George Washington University School of Medicine and Health Sciences (SMHS) invites applications and nominations for the position of chair of the Department of Microbiology, Immunology, & Tropical Medicine (MITM).

Apply here: https://www.gwu.jobs/postings/51785

The HPTN is seeking applicants for a 50% academic ID doctor to serve as a clinical trials physician for some of the major studies.  This is a great opportunity for emerging investigators interested in HIV prevention research.

...

Looking for a NIH Program Official in Your Research Area?

For years researchers have used the Matchmaker feature in NIH RePORTER to identify NIH-funded projects similar to their supplied abstracts, research bios, or other scientific text. Matchmaker was recently enhanced to make it just as easy to identify NIH program officials whose portfolios include projects in your research area.

After entering your scientific text (up to 15,000 characters), Matchmaker will analyze the key terms and concepts to identify up to 500 similar projects. Those projects will...

The second iteration of the FOA Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional)” was just published.

Here it is. ...

This is an opportunity that may be of interest to early-stage HIV investigators who would like an opportunity for short-term training. This proposal is not tied to the CFAR grant and is a standalone submission to CDRF but funded by OAR.

• Early-stage investigators from Brazil, China, India, Russia, South Africa, and the United States of America
• Each up to $25,000 United States Dollars (USD) for up to 3 months of short-term...

The Department of Medicine (DOM) at MGH has an initiative to support faculty applying for R01 grants.

They are offering the opportunity for pre-submission review of drafts of R01 grants. Dozens of NIH-funded DOM research faculty have volunteered to make themselves available to read and provide feedback. Although optional, they hope that many investigators will take advantage of this pre-review process.

Details on how to participate in pre-submission review of R01 grants can be found...

Go To Survey: ...

The UNC HIV Cure Center in the Institute of Global Health and Infectious Disease, Department of Medicine at the University of North Carolina at Chapel Hill invites applications for research technician, research track faculty and postdoctoral positions.   The UNC HIV Cure Center is a partnership between the University of North Carolina at Chapel Hill and GlaxoSmithKline.  The UNC HIV Cure Center (http://unchivcurecenter.org...

January 18, 2018
RE: Inter‐CFAR Workshop on Partnerships between HBCUs and CFARs

Dear Colleagues,

On March 22, 2018 the Tennessee Center for AIDS Research (CFAR) will host an Inter‐CFAR workshop entitled
“Partnerships between HBCUs and CFARs – Addressing the Underrepresentation of African American
Investigators in HIV/AIDS”. This Workshop is intended to: 1) foster synergistic partnerships between historically
black colleges and universities (HBCUs) and CFARs concentrating on understanding and addressing the
underrepresentation of African...